| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Copper | 14 | 2018 | 165 | 3.820 |
Why?
|
| Hydrolases | 14 | 2021 | 123 | 3.420 |
Why?
|
| Cation Transport Proteins | 16 | 2018 | 199 | 3.410 |
Why?
|
| Argininosuccinate Synthase | 13 | 2017 | 54 | 3.060 |
Why?
|
| Arginine | 16 | 2021 | 500 | 2.980 |
Why?
|
| Cisplatin | 21 | 2018 | 2432 | 2.950 |
Why?
|
| Polyethylene Glycols | 14 | 2021 | 615 | 2.360 |
Why?
|
| Glutamate-Cysteine Ligase | 15 | 2008 | 26 | 1.950 |
Why?
|
| Drug Resistance, Neoplasm | 30 | 2021 | 5178 | 1.940 |
Why?
|
| Sp1 Transcription Factor | 4 | 2016 | 188 | 1.510 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 4 | 2017 | 376 | 1.420 |
Why?
|
| Drug Resistance | 23 | 2003 | 587 | 1.370 |
Why?
|
| Drug Resistance, Multiple | 12 | 2009 | 204 | 1.260 |
Why?
|
| ATP-Binding Cassette Transporters | 12 | 2001 | 299 | 1.220 |
Why?
|
| Chelating Agents | 6 | 2015 | 127 | 1.210 |
Why?
|
| Genes, MDR | 6 | 2009 | 38 | 1.180 |
Why?
|
| Liver Neoplasms, Experimental | 11 | 2000 | 196 | 1.140 |
Why?
|
| Proto-Oncogene Proteins c-myc | 4 | 2016 | 810 | 1.060 |
Why?
|
| Multidrug Resistance-Associated Proteins | 18 | 2009 | 83 | 1.050 |
Why?
|
| Antineoplastic Agents | 25 | 2018 | 14289 | 0.960 |
Why?
|
| Glutamine | 3 | 2017 | 299 | 0.940 |
Why?
|
| RNA, Messenger | 40 | 2012 | 6150 | 0.940 |
Why?
|
| Homeostasis | 5 | 2018 | 950 | 0.940 |
Why?
|
| Gene Expression Regulation, Neoplastic | 29 | 2018 | 8873 | 0.900 |
Why?
|
| Transcription, Genetic | 16 | 2018 | 3154 | 0.850 |
Why?
|
| Membrane Glycoproteins | 14 | 1994 | 1073 | 0.850 |
Why?
|
| Biological Transport | 12 | 2015 | 597 | 0.800 |
Why?
|
| Promoter Regions, Genetic | 11 | 2017 | 3101 | 0.790 |
Why?
|
| Gene Expression Regulation | 13 | 2017 | 4053 | 0.770 |
Why?
|
| Up-Regulation | 7 | 2015 | 2450 | 0.760 |
Why?
|
| DNA | 28 | 2016 | 2693 | 0.750 |
Why?
|
| Glutathione | 9 | 2008 | 368 | 0.740 |
Why?
|
| Transfection | 21 | 2016 | 2944 | 0.710 |
Why?
|
| MAP Kinase Signaling System | 4 | 2016 | 848 | 0.710 |
Why?
|
| Gene Amplification | 7 | 2006 | 731 | 0.700 |
Why?
|
| Carrier Proteins | 12 | 1998 | 2022 | 0.650 |
Why?
|
| Chromosome Fragile Sites | 4 | 2006 | 38 | 0.630 |
Why?
|
| Histone Deacetylase 2 | 1 | 2017 | 35 | 0.620 |
Why?
|
| Melanoma | 12 | 2021 | 5317 | 0.600 |
Why?
|
| E1A-Associated p300 Protein | 1 | 2017 | 92 | 0.590 |
Why?
|
| Cell Line, Tumor | 27 | 2021 | 14551 | 0.590 |
Why?
|
| Platinum | 2 | 2018 | 138 | 0.570 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 2 | 2016 | 301 | 0.520 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2017 | 287 | 0.510 |
Why?
|
| Base Sequence | 25 | 2009 | 4917 | 0.510 |
Why?
|
| Molecular Sequence Data | 22 | 2008 | 6089 | 0.510 |
Why?
|
| Down-Regulation | 6 | 2016 | 2074 | 0.500 |
Why?
|
| Neoplasms | 13 | 2017 | 15193 | 0.490 |
Why?
|
| Reactive Oxygen Species | 6 | 2017 | 987 | 0.470 |
Why?
|
| Sp4 Transcription Factor | 2 | 2010 | 6 | 0.460 |
Why?
|
| Cadmium | 2 | 2008 | 57 | 0.460 |
Why?
|
| Metals, Heavy | 1 | 2013 | 32 | 0.460 |
Why?
|
| Genes | 13 | 1995 | 491 | 0.450 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2016 | 622 | 0.440 |
Why?
|
| Tumor Cells, Cultured | 24 | 2005 | 5395 | 0.430 |
Why?
|
| Oxidative Stress | 6 | 2017 | 1129 | 0.420 |
Why?
|
| Chromosomes | 10 | 1989 | 244 | 0.420 |
Why?
|
| Animals | 77 | 2018 | 59536 | 0.420 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2015 | 650 | 0.410 |
Why?
|
| Cell Line | 31 | 2017 | 5114 | 0.400 |
Why?
|
| Cricetinae | 16 | 2006 | 706 | 0.390 |
Why?
|
| Homeodomain Proteins | 1 | 2016 | 1143 | 0.390 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 1 | 2015 | 661 | 0.390 |
Why?
|
| TNF-Related Apoptosis-Inducing Ligand | 3 | 2021 | 205 | 0.380 |
Why?
|
| Carcinoma, Small Cell | 4 | 2008 | 408 | 0.380 |
Why?
|
| Oxidation-Reduction | 5 | 2018 | 717 | 0.380 |
Why?
|
| Autophagy | 7 | 2021 | 927 | 0.360 |
Why?
|
| Repressor Proteins | 1 | 2017 | 1664 | 0.350 |
Why?
|
| Signal Transduction | 11 | 2021 | 11965 | 0.340 |
Why?
|
| Humans | 88 | 2021 | 261506 | 0.340 |
Why?
|
| Doxorubicin | 13 | 2005 | 3005 | 0.340 |
Why?
|
| Spermatocytes | 2 | 2006 | 43 | 0.340 |
Why?
|
| Multigene Family | 4 | 2008 | 425 | 0.330 |
Why?
|
| Glucose | 2 | 2017 | 1248 | 0.320 |
Why?
|
| Nimustine | 2 | 1997 | 2 | 0.320 |
Why?
|
| Nucleic Acid Hybridization | 21 | 1994 | 542 | 0.310 |
Why?
|
| Hepatitis B virus | 4 | 2002 | 217 | 0.310 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2015 | 2488 | 0.290 |
Why?
|
| Chromosome Fragility | 2 | 1998 | 33 | 0.290 |
Why?
|
| DNA Methylation | 1 | 2016 | 2669 | 0.280 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2009 | 703 | 0.280 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 4 | 2016 | 15862 | 0.280 |
Why?
|
| Chromosomes, Mammalian | 1 | 2006 | 59 | 0.280 |
Why?
|
| Gene Expression | 13 | 2017 | 3570 | 0.280 |
Why?
|
| Adenosine Triphosphatases | 2 | 2011 | 435 | 0.270 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 3 | 2010 | 1265 | 0.270 |
Why?
|
| Cell Death | 3 | 2017 | 671 | 0.260 |
Why?
|
| Proteolysis | 3 | 2017 | 370 | 0.260 |
Why?
|
| Hepatitis B Surface Antigens | 3 | 2002 | 84 | 0.260 |
Why?
|
| Liver Neoplasms | 10 | 2012 | 4557 | 0.260 |
Why?
|
| Antibiotics, Antineoplastic | 6 | 2004 | 726 | 0.250 |
Why?
|
| Mice | 35 | 2017 | 34495 | 0.250 |
Why?
|
| Molecular Targeted Therapy | 2 | 2015 | 2330 | 0.240 |
Why?
|
| Liver | 9 | 2000 | 2961 | 0.240 |
Why?
|
| Adipocytes | 1 | 2006 | 305 | 0.240 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2005 | 334 | 0.240 |
Why?
|
| NF-kappa B | 3 | 2001 | 1549 | 0.240 |
Why?
|
| Amino Acid Sequence | 10 | 2007 | 4233 | 0.230 |
Why?
|
| Blotting, Western | 8 | 2012 | 3536 | 0.230 |
Why?
|
| Carboplatin | 3 | 2013 | 823 | 0.230 |
Why?
|
| Colorectal Neoplasms | 6 | 2005 | 3578 | 0.230 |
Why?
|
| Trientine | 2 | 2013 | 11 | 0.230 |
Why?
|
| 2-Acetylaminofluorene | 2 | 2001 | 11 | 0.230 |
Why?
|
| Chromatin | 10 | 1985 | 942 | 0.220 |
Why?
|
| DNA, Complementary | 6 | 2006 | 869 | 0.220 |
Why?
|
| Cycloheximide | 3 | 1997 | 97 | 0.220 |
Why?
|
| Arginase | 2 | 2015 | 48 | 0.220 |
Why?
|
| Gene Regulatory Networks | 2 | 2017 | 677 | 0.220 |
Why?
|
| Membrane Transport Proteins | 6 | 2007 | 244 | 0.210 |
Why?
|
| Stress, Physiological | 3 | 2017 | 492 | 0.200 |
Why?
|
| Apoptosis | 9 | 2021 | 7591 | 0.200 |
Why?
|
| Bleomycin | 8 | 1981 | 467 | 0.200 |
Why?
|
| Cloning, Molecular | 8 | 2006 | 1213 | 0.200 |
Why?
|
| Carcinogens | 2 | 2001 | 384 | 0.200 |
Why?
|
| Liver Regeneration | 2 | 1993 | 134 | 0.200 |
Why?
|
| Fresh Water | 1 | 2000 | 18 | 0.200 |
Why?
|
| Mice, Nude | 6 | 2017 | 4307 | 0.200 |
Why?
|
| Soil Pollutants | 1 | 2000 | 12 | 0.190 |
Why?
|
| RNA Interference | 3 | 2016 | 1408 | 0.190 |
Why?
|
| Daunorubicin | 2 | 1998 | 301 | 0.190 |
Why?
|
| Tumor Suppressor Protein p53 | 4 | 2002 | 3552 | 0.190 |
Why?
|
| Ovalbumin | 6 | 1982 | 254 | 0.190 |
Why?
|
| Water Pollutants, Chemical | 1 | 2000 | 37 | 0.190 |
Why?
|
| Lung Neoplasms | 9 | 2017 | 11538 | 0.190 |
Why?
|
| I-kappa B Proteins | 1 | 2001 | 170 | 0.190 |
Why?
|
| Cricetulus | 7 | 2006 | 205 | 0.180 |
Why?
|
| Epithelial Cells | 2 | 2005 | 1818 | 0.180 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 2000 | 195 | 0.180 |
Why?
|
| Proto-Oncogene Proteins B-raf | 2 | 2017 | 1283 | 0.180 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2011 | 518 | 0.170 |
Why?
|
| Zinc Fingers | 2 | 2011 | 205 | 0.170 |
Why?
|
| Interleukin-1 | 1 | 2000 | 461 | 0.170 |
Why?
|
| Cell Survival | 6 | 2017 | 3045 | 0.170 |
Why?
|
| Recombinant Fusion Proteins | 6 | 2002 | 1555 | 0.170 |
Why?
|
| Carcinoma, Hepatocellular | 5 | 2008 | 2027 | 0.170 |
Why?
|
| Protozoan Proteins | 2 | 2002 | 114 | 0.170 |
Why?
|
| Oxidants | 2 | 2005 | 49 | 0.160 |
Why?
|
| Cell Differentiation | 3 | 2006 | 4078 | 0.160 |
Why?
|
| Binding Sites | 7 | 2009 | 2171 | 0.160 |
Why?
|
| Ki-67 Antigen | 1 | 2000 | 666 | 0.160 |
Why?
|
| Breast Neoplasms | 5 | 2010 | 15694 | 0.160 |
Why?
|
| Sin3 Histone Deacetylase and Corepressor Complex | 1 | 2017 | 13 | 0.160 |
Why?
|
| Neoplasm Proteins | 6 | 2009 | 3230 | 0.160 |
Why?
|
| Viral Envelope Proteins | 3 | 1996 | 207 | 0.160 |
Why?
|
| beta-Galactosidase | 2 | 1996 | 211 | 0.150 |
Why?
|
| Protein Synthesis Inhibitors | 1 | 1997 | 71 | 0.150 |
Why?
|
| Protein Biosynthesis | 7 | 2006 | 889 | 0.150 |
Why?
|
| Hypoxia-Inducible Factor-Proline Dioxygenases | 1 | 2017 | 52 | 0.150 |
Why?
|
| Enzyme Induction | 4 | 2002 | 249 | 0.150 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 6 | 2012 | 3639 | 0.150 |
Why?
|
| Genes, p53 | 2 | 2004 | 1090 | 0.150 |
Why?
|
| Adenoma | 1 | 2002 | 716 | 0.140 |
Why?
|
| Nitric Oxide | 1 | 2000 | 644 | 0.140 |
Why?
|
| Arsenites | 1 | 1996 | 18 | 0.140 |
Why?
|
| Defective Viruses | 1 | 1996 | 28 | 0.140 |
Why?
|
| Biological Transport, Active | 1 | 2016 | 131 | 0.140 |
Why?
|
| Models, Biological | 5 | 2017 | 3254 | 0.140 |
Why?
|
| DNA, Recombinant | 1 | 1996 | 121 | 0.140 |
Why?
|
| DNA, Neoplasm | 4 | 2008 | 1910 | 0.130 |
Why?
|
| Mitosis | 3 | 2006 | 615 | 0.130 |
Why?
|
| Restriction Mapping | 3 | 1996 | 264 | 0.130 |
Why?
|
| Cell Nucleus | 7 | 1999 | 1620 | 0.130 |
Why?
|
| Plasmodium | 1 | 1995 | 8 | 0.130 |
Why?
|
| Zinc | 1 | 1996 | 188 | 0.130 |
Why?
|
| Adenoviruses, Human | 1 | 1996 | 181 | 0.130 |
Why?
|
| Rats | 9 | 2001 | 6086 | 0.130 |
Why?
|
| Proteasome Inhibitors | 1 | 2016 | 231 | 0.130 |
Why?
|
| Open Reading Frames | 2 | 2006 | 250 | 0.130 |
Why?
|
| Gene Transfer Techniques | 2 | 1996 | 716 | 0.130 |
Why?
|
| Genes, Reporter | 4 | 2001 | 798 | 0.130 |
Why?
|
| Protein Processing, Post-Translational | 2 | 1997 | 803 | 0.130 |
Why?
|
| Platinum Compounds | 1 | 2015 | 131 | 0.130 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1995 | 220 | 0.130 |
Why?
|
| DNA-Binding Proteins | 6 | 2017 | 4821 | 0.130 |
Why?
|
| Chickens | 11 | 1987 | 523 | 0.130 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 1995 | 85 | 0.130 |
Why?
|
| Protein Binding | 3 | 2009 | 3438 | 0.130 |
Why?
|
| DNA Primers | 5 | 2009 | 1399 | 0.130 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2017 | 413 | 0.130 |
Why?
|
| Leukotriene C4 | 3 | 1998 | 8 | 0.120 |
Why?
|
| Matrix Metalloproteinases | 1 | 2005 | 143 | 0.120 |
Why?
|
| Epirubicin | 1 | 1994 | 157 | 0.120 |
Why?
|
| Hepatic Veins | 1 | 1994 | 58 | 0.120 |
Why?
|
| Friend murine leukemia virus | 1 | 1994 | 5 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-jun | 2 | 1991 | 166 | 0.120 |
Why?
|
| Retroviridae Infections | 1 | 1994 | 17 | 0.120 |
Why?
|
| RNA, Neoplasm | 6 | 1996 | 771 | 0.120 |
Why?
|
| Protein Kinase Inhibitors | 3 | 2017 | 4757 | 0.120 |
Why?
|
| Glyceraldehyde-3-Phosphate Dehydrogenases | 2 | 1985 | 41 | 0.120 |
Why?
|
| Verapamil | 1 | 1994 | 78 | 0.120 |
Why?
|
| Uterus | 2 | 1997 | 678 | 0.120 |
Why?
|
| Rhodamines | 1 | 1994 | 49 | 0.120 |
Why?
|
| Transcriptional Activation | 2 | 1995 | 1070 | 0.120 |
Why?
|
| Leukemia, Experimental | 1 | 1994 | 78 | 0.120 |
Why?
|
| Cell Proliferation | 4 | 2015 | 7226 | 0.120 |
Why?
|
| Mutagenesis, Site-Directed | 4 | 2009 | 611 | 0.120 |
Why?
|
| Female | 33 | 2017 | 141928 | 0.120 |
Why?
|
| Glioma | 3 | 2005 | 1963 | 0.120 |
Why?
|
| Chemotherapy, Cancer, Regional Perfusion | 1 | 1994 | 169 | 0.110 |
Why?
|
| Immunohistochemistry | 5 | 2011 | 7548 | 0.110 |
Why?
|
| Epithelium | 4 | 2005 | 720 | 0.110 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2016 | 612 | 0.110 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2016 | 4938 | 0.110 |
Why?
|
| Chromosome Aberrations | 3 | 1989 | 1960 | 0.110 |
Why?
|
| Protein Kinases | 2 | 2008 | 874 | 0.110 |
Why?
|
| Immunoblotting | 2 | 2009 | 886 | 0.110 |
Why?
|
| Tumor Virus Infections | 1 | 1994 | 224 | 0.110 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 1995 | 445 | 0.110 |
Why?
|
| RNA | 5 | 2005 | 1013 | 0.100 |
Why?
|
| Quinone Reductases | 1 | 1991 | 6 | 0.100 |
Why?
|
| Thioredoxins | 1 | 2012 | 50 | 0.100 |
Why?
|
| Phosphatidylinositol 3-Kinase | 1 | 2012 | 86 | 0.100 |
Why?
|
| Heterochromatin | 5 | 1979 | 83 | 0.100 |
Why?
|
| Copper-transporting ATPases | 2 | 2011 | 44 | 0.100 |
Why?
|
| Caspases | 2 | 2012 | 661 | 0.100 |
Why?
|
| Mice, Inbred Strains | 4 | 1995 | 521 | 0.100 |
Why?
|
| Conserved Sequence | 3 | 2006 | 469 | 0.100 |
Why?
|
| Energy Metabolism | 1 | 2017 | 992 | 0.100 |
Why?
|
| Insulin | 1 | 1997 | 1454 | 0.100 |
Why?
|
| Protein Stability | 1 | 2012 | 370 | 0.100 |
Why?
|
| Chromosome Mapping | 5 | 1996 | 1471 | 0.100 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2016 | 3821 | 0.100 |
Why?
|
| Mice, Transgenic | 5 | 2002 | 4143 | 0.090 |
Why?
|
| Genetic Vectors | 1 | 1996 | 1694 | 0.090 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 1077 | 0.090 |
Why?
|
| Precancerous Conditions | 2 | 1994 | 1058 | 0.090 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 1991 | 200 | 0.090 |
Why?
|
| Ubiquitin | 1 | 2012 | 344 | 0.090 |
Why?
|
| Genes, myc | 2 | 2010 | 358 | 0.090 |
Why?
|
| Cell Separation | 1 | 1992 | 612 | 0.090 |
Why?
|
| Tissue Distribution | 2 | 2005 | 875 | 0.090 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2012 | 460 | 0.090 |
Why?
|
| Immune Tolerance | 1 | 2002 | 403 | 0.090 |
Why?
|
| Antigens, Neoplasm | 2 | 2017 | 1506 | 0.090 |
Why?
|
| Y Chromosome | 3 | 1985 | 77 | 0.090 |
Why?
|
| Lipids | 1 | 2013 | 644 | 0.090 |
Why?
|
| CHO Cells | 3 | 1994 | 311 | 0.090 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2010 | 287 | 0.080 |
Why?
|
| Genes, ras | 1 | 2012 | 667 | 0.080 |
Why?
|
| Deoxyribonucleases | 6 | 1981 | 46 | 0.080 |
Why?
|
| Buthionine Sulfoximine | 1 | 2008 | 41 | 0.080 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2008 | 50 | 0.080 |
Why?
|
| DNA Restriction Enzymes | 6 | 1984 | 117 | 0.080 |
Why?
|
| Dexamethasone | 1 | 1993 | 1450 | 0.080 |
Why?
|
| Genetic Therapy | 1 | 1996 | 1616 | 0.080 |
Why?
|
| RNA Probes | 3 | 1993 | 44 | 0.080 |
Why?
|
| alpha-Fetoproteins | 2 | 2002 | 237 | 0.080 |
Why?
|
| Digestive System | 1 | 1988 | 114 | 0.080 |
Why?
|
| Antimetabolites, Antineoplastic | 1 | 1994 | 1299 | 0.080 |
Why?
|
| DNA Damage | 3 | 2004 | 1954 | 0.080 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2012 | 519 | 0.080 |
Why?
|
| Cells, Cultured | 6 | 2006 | 5637 | 0.070 |
Why?
|
| Time Factors | 4 | 2016 | 12926 | 0.070 |
Why?
|
| Catalytic Domain | 1 | 2008 | 303 | 0.070 |
Why?
|
| Tubulin | 1 | 1987 | 169 | 0.070 |
Why?
|
| Flow Cytometry | 3 | 2001 | 3033 | 0.070 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2013 | 1678 | 0.070 |
Why?
|
| Organoplatinum Compounds | 2 | 2011 | 702 | 0.070 |
Why?
|
| Polymerase Chain Reaction | 6 | 2004 | 3203 | 0.070 |
Why?
|
| Nucleosomes | 3 | 1982 | 143 | 0.070 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2008 | 566 | 0.070 |
Why?
|
| DNA Probes | 3 | 1991 | 217 | 0.070 |
Why?
|
| Mice, Inbred BALB C | 3 | 2015 | 2314 | 0.070 |
Why?
|
| Ovarian Neoplasms | 2 | 2012 | 4638 | 0.070 |
Why?
|
| Biotinylation | 1 | 2005 | 47 | 0.070 |
Why?
|
| Deoxyribonuclease I | 5 | 1987 | 67 | 0.070 |
Why?
|
| Skin Neoplasms | 3 | 2012 | 4654 | 0.070 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2008 | 1062 | 0.070 |
Why?
|
| WT1 Proteins | 1 | 2006 | 106 | 0.070 |
Why?
|
| Cell Division | 3 | 2000 | 2489 | 0.070 |
Why?
|
| HL-60 Cells | 2 | 1996 | 302 | 0.070 |
Why?
|
| Sulindac | 1 | 2005 | 51 | 0.070 |
Why?
|
| Clinical Trials as Topic | 2 | 2013 | 3719 | 0.070 |
Why?
|
| Antigens, Polyomavirus Transforming | 2 | 1996 | 110 | 0.060 |
Why?
|
| Adipogenesis | 1 | 2006 | 105 | 0.060 |
Why?
|
| Half-Life | 1 | 2005 | 259 | 0.060 |
Why?
|
| HeLa Cells | 4 | 2006 | 1643 | 0.060 |
Why?
|
| Peromyscus | 3 | 1979 | 6 | 0.060 |
Why?
|
| RNA, Small Interfering | 2 | 2008 | 2216 | 0.060 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2005 | 129 | 0.060 |
Why?
|
| Leukemia Virus, Murine | 1 | 1984 | 20 | 0.060 |
Why?
|
| Glutathione Transferase | 1 | 1996 | 359 | 0.060 |
Why?
|
| Sirolimus | 2 | 2008 | 814 | 0.060 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2007 | 249 | 0.060 |
Why?
|
| Histone Acetyltransferases | 1 | 2006 | 411 | 0.060 |
Why?
|
| Hydroquinones | 2 | 2007 | 28 | 0.060 |
Why?
|
| Chromosome Disorders | 1 | 1987 | 417 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 2 | 2004 | 1487 | 0.060 |
Why?
|
| Protein Subunits | 1 | 2005 | 274 | 0.060 |
Why?
|
| Collagen Type I | 1 | 2005 | 204 | 0.060 |
Why?
|
| Mammary Glands, Animal | 2 | 2005 | 533 | 0.060 |
Why?
|
| Spermatogenesis | 1 | 2006 | 308 | 0.060 |
Why?
|
| Caenorhabditis elegans | 1 | 2005 | 268 | 0.060 |
Why?
|
| Enzyme Activation | 2 | 2012 | 1764 | 0.060 |
Why?
|
| 3T3 Cells | 2 | 1994 | 355 | 0.060 |
Why?
|
| In Situ Hybridization | 1 | 2005 | 1037 | 0.060 |
Why?
|
| Zidovudine | 1 | 2003 | 40 | 0.060 |
Why?
|
| Peptide Fragments | 3 | 1998 | 1271 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 4 | 1996 | 6942 | 0.060 |
Why?
|
| Oxygen Consumption | 2 | 2017 | 401 | 0.060 |
Why?
|
| Receptors, Progesterone | 1 | 1989 | 1392 | 0.060 |
Why?
|
| Ribosomal Proteins | 1 | 2003 | 118 | 0.060 |
Why?
|
| Oncogenes | 1 | 2006 | 673 | 0.050 |
Why?
|
| Chromosomal Proteins, Non-Histone | 2 | 1982 | 362 | 0.050 |
Why?
|
| Nucleoside Deaminases | 1 | 2002 | 33 | 0.050 |
Why?
|
| Kinetics | 5 | 1998 | 2049 | 0.050 |
Why?
|
| MutS Homolog 3 Protein | 1 | 2002 | 12 | 0.050 |
Why?
|
| Male | 14 | 2013 | 123000 | 0.050 |
Why?
|
| Cell Transformation, Neoplastic | 4 | 2006 | 2359 | 0.050 |
Why?
|
| Meiosis | 1 | 1983 | 166 | 0.050 |
Why?
|
| Hybrid Cells | 2 | 1995 | 128 | 0.050 |
Why?
|
| Endodeoxyribonucleases | 1 | 1982 | 105 | 0.050 |
Why?
|
| Genome | 1 | 2006 | 672 | 0.050 |
Why?
|
| Antimalarials | 1 | 2002 | 55 | 0.050 |
Why?
|
| Ribonucleases | 1 | 2002 | 88 | 0.050 |
Why?
|
| Sequence Homology, Nucleic Acid | 2 | 1993 | 354 | 0.050 |
Why?
|
| Hyperplasia | 2 | 1994 | 557 | 0.050 |
Why?
|
| Gene Expression Regulation, Leukemic | 2 | 1996 | 560 | 0.050 |
Why?
|
| Zinostatin | 2 | 1978 | 4 | 0.050 |
Why?
|
| RNA, Viral | 1 | 1984 | 671 | 0.050 |
Why?
|
| Sequence Deletion | 1 | 2004 | 875 | 0.050 |
Why?
|
| Fibroblasts | 2 | 1986 | 1682 | 0.050 |
Why?
|
| Transcription Factors | 1 | 1995 | 5270 | 0.050 |
Why?
|
| Paraffin Embedding | 1 | 2002 | 226 | 0.050 |
Why?
|
| Volatilization | 1 | 2000 | 7 | 0.050 |
Why?
|
| Nitric Oxide Donors | 1 | 2000 | 51 | 0.050 |
Why?
|
| Disease Models, Animal | 3 | 2017 | 7222 | 0.050 |
Why?
|
| Taiwan | 1 | 2000 | 93 | 0.050 |
Why?
|
| Industry | 1 | 2000 | 53 | 0.050 |
Why?
|
| Prodrugs | 1 | 2002 | 217 | 0.050 |
Why?
|
| Gene Expression Profiling | 3 | 2005 | 5159 | 0.050 |
Why?
|
| Spermatozoa | 1 | 1983 | 315 | 0.050 |
Why?
|
| Crosses, Genetic | 1 | 2000 | 241 | 0.050 |
Why?
|
| Aspartate Aminotransferases | 1 | 2000 | 153 | 0.050 |
Why?
|
| Ceramides | 1 | 2000 | 95 | 0.050 |
Why?
|
| Ploidies | 1 | 2000 | 248 | 0.050 |
Why?
|
| Conalbumin | 1 | 1979 | 2 | 0.050 |
Why?
|
| Structure-Activity Relationship | 3 | 2009 | 931 | 0.050 |
Why?
|
| Hydrogen Peroxide | 1 | 2001 | 217 | 0.050 |
Why?
|
| Acetylcysteine | 1 | 2001 | 143 | 0.050 |
Why?
|
| Trans-Activators | 1 | 2006 | 1555 | 0.040 |
Why?
|
| Egg Proteins | 1 | 1979 | 66 | 0.040 |
Why?
|
| Alanine Transaminase | 1 | 2000 | 227 | 0.040 |
Why?
|
| Endonucleases | 2 | 1980 | 178 | 0.040 |
Why?
|
| Nitric Oxide Synthase Type II | 1 | 2000 | 261 | 0.040 |
Why?
|
| Nitric Oxide Synthase | 1 | 2000 | 314 | 0.040 |
Why?
|
| Biopolymers | 1 | 2009 | 38 | 0.040 |
Why?
|
| Blotting, Northern | 2 | 2005 | 682 | 0.040 |
Why?
|
| I-kappa B Kinase | 1 | 2001 | 250 | 0.040 |
Why?
|
| Immunoenzyme Techniques | 1 | 2002 | 1165 | 0.040 |
Why?
|
| Glycolysis | 2 | 2017 | 519 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2005 | 2927 | 0.040 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2005 | 1498 | 0.040 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 2 | 1994 | 362 | 0.040 |
Why?
|
| Subcellular Fractions | 1 | 1998 | 201 | 0.040 |
Why?
|
| Ovary | 3 | 1987 | 668 | 0.040 |
Why?
|
| Transcription Factor AP-1 | 1 | 1999 | 246 | 0.040 |
Why?
|
| Arsenates | 1 | 1997 | 17 | 0.040 |
Why?
|
| Disease-Free Survival | 1 | 2010 | 10001 | 0.040 |
Why?
|
| Mitochondria | 2 | 2017 | 1282 | 0.040 |
Why?
|
| Dactinomycin | 1 | 1997 | 145 | 0.040 |
Why?
|
| Ubiquitins | 1 | 2017 | 86 | 0.040 |
Why?
|
| Riluzole | 1 | 2017 | 22 | 0.040 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 3 | 2002 | 568 | 0.040 |
Why?
|
| Immunologic Surveillance | 1 | 2017 | 60 | 0.040 |
Why?
|
| Antibodies | 2 | 1997 | 838 | 0.040 |
Why?
|
| Leukemia | 1 | 2006 | 1635 | 0.040 |
Why?
|
| NAD | 1 | 2017 | 89 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-raf | 1 | 1997 | 80 | 0.040 |
Why?
|
| Erythrocytes | 4 | 1982 | 339 | 0.040 |
Why?
|
| Electrophoresis, Agar Gel | 3 | 1985 | 82 | 0.040 |
Why?
|
| Treatment Outcome | 3 | 2013 | 32848 | 0.040 |
Why?
|
| Methylation | 3 | 1984 | 597 | 0.040 |
Why?
|
| TOR Serine-Threonine Kinases | 3 | 2010 | 1546 | 0.040 |
Why?
|
| Organ Specificity | 2 | 2006 | 699 | 0.040 |
Why?
|
| Receptors, Metabotropic Glutamate | 1 | 2017 | 63 | 0.040 |
Why?
|
| Autoradiography | 3 | 1985 | 132 | 0.040 |
Why?
|
| Neoadjuvant Therapy | 1 | 2010 | 4975 | 0.040 |
Why?
|
| Mutation | 4 | 2016 | 15179 | 0.040 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 1999 | 639 | 0.040 |
Why?
|
| Mucin-1 | 1 | 1997 | 127 | 0.040 |
Why?
|
| Chlorambucil | 1 | 1996 | 26 | 0.040 |
Why?
|
| Oviducts | 3 | 1982 | 149 | 0.040 |
Why?
|
| Prostaglandins A, Synthetic | 1 | 1996 | 1 | 0.040 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2011 | 5319 | 0.040 |
Why?
|
| Caspase 3 | 2 | 2012 | 471 | 0.040 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2017 | 299 | 0.030 |
Why?
|
| DNA Footprinting | 1 | 1995 | 34 | 0.030 |
Why?
|
| Globins | 3 | 1982 | 73 | 0.030 |
Why?
|
| Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 1995 | 15 | 0.030 |
Why?
|
| Amanitins | 1 | 1995 | 5 | 0.030 |
Why?
|
| Templates, Genetic | 2 | 1991 | 86 | 0.030 |
Why?
|
| Mice, Inbred ICR | 1 | 1996 | 239 | 0.030 |
Why?
|
| Glutamic Acid | 1 | 2017 | 309 | 0.030 |
Why?
|
| Polylysine | 1 | 1995 | 17 | 0.030 |
Why?
|
| Tissue Inhibitor of Metalloproteinases | 1 | 2005 | 43 | 0.030 |
Why?
|
| Citrullinemia | 1 | 2015 | 19 | 0.030 |
Why?
|
| Neoplasm Transplantation | 2 | 2002 | 1519 | 0.030 |
Why?
|
| DNA, Bacterial | 3 | 1973 | 558 | 0.030 |
Why?
|
| Immunity | 1 | 2017 | 342 | 0.030 |
Why?
|
| Bacillus subtilis | 3 | 1973 | 54 | 0.030 |
Why?
|
| Injections, Intravenous | 1 | 1996 | 573 | 0.030 |
Why?
|
| Poly A | 4 | 1977 | 87 | 0.030 |
Why?
|
| Isoenzymes | 1 | 2017 | 614 | 0.030 |
Why?
|
| Heterografts | 1 | 2017 | 733 | 0.030 |
Why?
|
| Aphidicolin | 1 | 1994 | 30 | 0.030 |
Why?
|
| Molecular Weight | 4 | 1982 | 629 | 0.030 |
Why?
|
| Liver Circulation | 1 | 1994 | 35 | 0.030 |
Why?
|
| Hemofiltration | 1 | 1994 | 20 | 0.030 |
Why?
|
| Vincristine | 3 | 1991 | 1511 | 0.030 |
Why?
|
| DNA Replication | 1 | 1979 | 744 | 0.030 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2017 | 589 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 1996 | 317 | 0.030 |
Why?
|
| Proteins | 1 | 1983 | 1963 | 0.030 |
Why?
|
| Fungal Proteins | 1 | 1995 | 254 | 0.030 |
Why?
|
| Infusions, Intra-Arterial | 1 | 1994 | 171 | 0.030 |
Why?
|
| Hypoxia | 1 | 2017 | 443 | 0.030 |
Why?
|
| Rhodamine 123 | 1 | 1994 | 11 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2009 | 1732 | 0.030 |
Why?
|
| Ceruloplasmin | 1 | 2013 | 35 | 0.030 |
Why?
|
| Leukocytes | 1 | 1976 | 422 | 0.030 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 1999 | 1538 | 0.030 |
Why?
|
| Vena Cava Filters | 1 | 1994 | 88 | 0.030 |
Why?
|
| Thymidine Kinase | 2 | 2003 | 193 | 0.030 |
Why?
|
| Rats, Inbred Strains | 2 | 1984 | 410 | 0.030 |
Why?
|
| Biological Evolution | 1 | 1995 | 278 | 0.030 |
Why?
|
| Middle Aged | 6 | 2013 | 86204 | 0.030 |
Why?
|
| Plasmids | 1 | 1995 | 837 | 0.030 |
Why?
|
| Kidney | 2 | 1993 | 2146 | 0.030 |
Why?
|
| Portal Vein | 1 | 1996 | 355 | 0.030 |
Why?
|
| Diethylnitrosamine | 1 | 1993 | 36 | 0.030 |
Why?
|
| Melphalan | 1 | 1996 | 834 | 0.030 |
Why?
|
| Enhancer Elements, Genetic | 1 | 1995 | 467 | 0.030 |
Why?
|
| Caspase 6 | 1 | 2012 | 15 | 0.030 |
Why?
|
| Caspase 10 | 1 | 2012 | 21 | 0.030 |
Why?
|
| Clone Cells | 1 | 1994 | 555 | 0.030 |
Why?
|
| Autophagy-Related Protein 5 | 1 | 2012 | 46 | 0.030 |
Why?
|
| Transduction, Genetic | 1 | 1994 | 475 | 0.030 |
Why?
|
| Beclin-1 | 1 | 2012 | 85 | 0.030 |
Why?
|
| MicroRNAs | 1 | 2006 | 2947 | 0.030 |
Why?
|
| Rats, Inbred F344 | 1 | 1993 | 224 | 0.030 |
Why?
|
| Caspase Inhibitors | 1 | 2012 | 95 | 0.030 |
Why?
|
| Tetraethylammonium Compounds | 1 | 1992 | 6 | 0.030 |
Why?
|
| Risk Factors | 1 | 2010 | 17523 | 0.030 |
Why?
|
| Cell Fractionation | 2 | 1983 | 68 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 2 | 2010 | 1493 | 0.030 |
Why?
|
| Calpain | 1 | 2012 | 64 | 0.030 |
Why?
|
| Caspase 8 | 1 | 2012 | 145 | 0.030 |
Why?
|
| Thymine | 1 | 1972 | 46 | 0.030 |
Why?
|
| Epitopes | 1 | 1995 | 685 | 0.030 |
Why?
|
| Fumarate Hydratase | 1 | 2012 | 13 | 0.030 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2017 | 854 | 0.030 |
Why?
|
| Colonic Neoplasms | 1 | 2000 | 1390 | 0.030 |
Why?
|
| Receptors, Glucocorticoid | 1 | 1993 | 192 | 0.030 |
Why?
|
| Fatty Acid Synthases | 1 | 2012 | 24 | 0.030 |
Why?
|
| Caspase 9 | 1 | 2012 | 189 | 0.030 |
Why?
|
| Catheterization | 1 | 1994 | 410 | 0.030 |
Why?
|
| Hepatitis B Antibodies | 1 | 2002 | 58 | 0.030 |
Why?
|
| Guanine | 1 | 1972 | 151 | 0.030 |
Why?
|
| Acetyl-CoA Carboxylase | 1 | 2012 | 54 | 0.030 |
Why?
|
| Killer Cells, Natural | 1 | 2017 | 904 | 0.030 |
Why?
|
| Saccharomyces cerevisiae | 1 | 1995 | 621 | 0.030 |
Why?
|
| Metaphase | 3 | 1982 | 107 | 0.030 |
Why?
|
| Cytosine | 1 | 1972 | 141 | 0.030 |
Why?
|
| Membrane Potential, Mitochondrial | 1 | 2012 | 133 | 0.030 |
Why?
|
| Polychlorinated Dibenzodioxins | 1 | 1991 | 13 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 1991 | 123 | 0.030 |
Why?
|
| Chimera | 1 | 1991 | 145 | 0.030 |
Why?
|
| Trifluoperazine | 1 | 1991 | 8 | 0.020 |
Why?
|
| Phenotype | 3 | 1994 | 6295 | 0.020 |
Why?
|
| Dimethylhydrazines | 1 | 1990 | 1 | 0.020 |
Why?
|
| 1,2-Dimethylhydrazine | 1 | 1990 | 3 | 0.020 |
Why?
|
| Hepatitis C | 1 | 2006 | 524 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 1995 | 862 | 0.020 |
Why?
|
| Methotrexate | 1 | 1994 | 999 | 0.020 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 1 | 1990 | 108 | 0.020 |
Why?
|
| Spleen | 2 | 2002 | 676 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2000 | 5710 | 0.020 |
Why?
|
| Niacinamide | 1 | 1992 | 421 | 0.020 |
Why?
|
| Aged | 5 | 2013 | 70117 | 0.020 |
Why?
|
| Hemodynamics | 1 | 1994 | 935 | 0.020 |
Why?
|
| Micronucleus Tests | 1 | 1989 | 20 | 0.020 |
Why?
|
| Receptors, Retinoic Acid | 1 | 1991 | 365 | 0.020 |
Why?
|
| Biomarkers, Tumor | 2 | 2005 | 10331 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2012 | 621 | 0.020 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2012 | 534 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 1995 | 2283 | 0.020 |
Why?
|
| Sequence Alignment | 1 | 1991 | 844 | 0.020 |
Why?
|
| Adoptive Transfer | 1 | 2002 | 446 | 0.020 |
Why?
|
| Adenine | 1 | 1972 | 631 | 0.020 |
Why?
|
| Enzyme Inhibitors | 1 | 1997 | 1879 | 0.020 |
Why?
|
| Genetic Diseases, Inborn | 2 | 2008 | 442 | 0.020 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 1997 | 1756 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 1994 | 2232 | 0.020 |
Why?
|
| Vinblastine | 1 | 1989 | 453 | 0.020 |
Why?
|
| Lymphocytes | 4 | 1982 | 1234 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2005 | 2508 | 0.020 |
Why?
|
| Phosphorylation | 2 | 2008 | 4804 | 0.020 |
Why?
|
| Drug Discovery | 1 | 2011 | 324 | 0.020 |
Why?
|
| Interphase | 2 | 1979 | 145 | 0.020 |
Why?
|
| Xenobiotics | 1 | 2008 | 44 | 0.020 |
Why?
|
| Tritium | 4 | 1974 | 200 | 0.020 |
Why?
|
| bcl-X Protein | 1 | 2008 | 196 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 1992 | 1338 | 0.020 |
Why?
|
| Nucleotide Mapping | 1 | 1987 | 24 | 0.020 |
Why?
|
| Sulfonamides | 1 | 1997 | 1823 | 0.020 |
Why?
|
| Brain Neoplasms | 1 | 2005 | 4849 | 0.020 |
Why?
|
| Hepatectomy | 1 | 1994 | 1011 | 0.020 |
Why?
|
| Interferon-gamma | 1 | 2002 | 1144 | 0.020 |
Why?
|
| Demecolcine | 1 | 1986 | 14 | 0.020 |
Why?
|
| Inflammation | 1 | 2017 | 2522 | 0.020 |
Why?
|
| Uterine Cervical Diseases | 1 | 1987 | 25 | 0.020 |
Why?
|
| Liver Diseases | 1 | 1992 | 574 | 0.020 |
Why?
|
| Body Weight | 1 | 2002 | 1293 | 0.020 |
Why?
|
| Chromosome Banding | 1 | 1987 | 256 | 0.020 |
Why?
|
| Intestinal Mucosa | 1 | 1993 | 1081 | 0.020 |
Why?
|
| Kelch-Like ECH-Associated Protein 1 | 1 | 2007 | 104 | 0.020 |
Why?
|
| Adult | 4 | 2013 | 77950 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2017 | 2864 | 0.020 |
Why?
|
| Carcinoembryonic Antigen | 1 | 1987 | 222 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2012 | 2315 | 0.020 |
Why?
|
| Anion Transport Proteins | 1 | 1996 | 34 | 0.020 |
Why?
|
| NIH 3T3 Cells | 1 | 2006 | 260 | 0.020 |
Why?
|
| Pregnancy | 2 | 1997 | 7573 | 0.020 |
Why?
|
| Gangliosides | 1 | 1976 | 95 | 0.020 |
Why?
|
| Adenocarcinoma | 1 | 1984 | 7789 | 0.020 |
Why?
|
| Protein Precursors | 1 | 1987 | 240 | 0.020 |
Why?
|
| E2F1 Transcription Factor | 1 | 2006 | 206 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2012 | 2803 | 0.020 |
Why?
|
| DNA Polymerase I | 1 | 1985 | 27 | 0.020 |
Why?
|
| Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2005 | 131 | 0.020 |
Why?
|
| Karyotyping | 1 | 1987 | 1022 | 0.020 |
Why?
|
| DNA, Single-Stranded | 2 | 1981 | 106 | 0.020 |
Why?
|
| Micrococcal Nuclease | 2 | 1981 | 10 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2017 | 3869 | 0.020 |
Why?
|
| Viral Proteins | 1 | 1987 | 435 | 0.010 |
Why?
|
| Nuclear Receptor Coactivator 3 | 1 | 2006 | 383 | 0.010 |
Why?
|
| Immunotherapy | 1 | 2017 | 3341 | 0.010 |
Why?
|
| Drug Delivery Systems | 1 | 2008 | 669 | 0.010 |
Why?
|
| Papillomaviridae | 1 | 1987 | 624 | 0.010 |
Why?
|
| Fetal Development | 1 | 2004 | 120 | 0.010 |
Why?
|
| Catalysis | 1 | 2003 | 250 | 0.010 |
Why?
|
| Neoplasm Staging | 2 | 2011 | 13658 | 0.010 |
Why?
|
| Deoxyribonuclease EcoRI | 1 | 1982 | 6 | 0.010 |
Why?
|
| Species Specificity | 1 | 1984 | 777 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 1994 | 8865 | 0.010 |
Why?
|
| Flucytosine | 1 | 2002 | 30 | 0.010 |
Why?
|
| Spermidine | 1 | 1982 | 8 | 0.010 |
Why?
|
| Cytosine Deaminase | 1 | 2002 | 39 | 0.010 |
Why?
|
| Estrogens | 1 | 2006 | 751 | 0.010 |
Why?
|
| Spermine | 1 | 1982 | 25 | 0.010 |
Why?
|
| Transplantation, Heterologous | 1 | 1984 | 1082 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2012 | 2819 | 0.010 |
Why?
|
| Electrophoresis | 1 | 1981 | 60 | 0.010 |
Why?
|
| Albumins | 1 | 1983 | 258 | 0.010 |
Why?
|
| Centrifugation, Density Gradient | 3 | 1973 | 124 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1982 | 585 | 0.010 |
Why?
|
| Biopsy | 1 | 1989 | 3443 | 0.010 |
Why?
|
| Point Mutation | 1 | 2003 | 769 | 0.010 |
Why?
|
| X Chromosome | 2 | 1977 | 339 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 2005 | 1152 | 0.010 |
Why?
|
| U937 Cells | 1 | 1999 | 171 | 0.010 |
Why?
|
| Micrococcus | 1 | 1979 | 7 | 0.010 |
Why?
|
| Ultracentrifugation | 2 | 1973 | 46 | 0.010 |
Why?
|
| Hot Temperature | 2 | 1974 | 281 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 1994 | 5542 | 0.010 |
Why?
|
| Venoms | 2 | 1973 | 23 | 0.010 |
Why?
|
| Receptors, Estrogen | 1 | 2006 | 2086 | 0.010 |
Why?
|
| Phosphoric Diester Hydrolases | 2 | 1973 | 103 | 0.010 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2005 | 1439 | 0.010 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1999 | 206 | 0.010 |
Why?
|
| Survival Rate | 1 | 2012 | 12221 | 0.010 |
Why?
|
| Binding, Competitive | 1 | 1998 | 300 | 0.010 |
Why?
|
| DNA, Satellite | 1 | 1977 | 36 | 0.010 |
Why?
|
| Drug Design | 1 | 2000 | 375 | 0.010 |
Why?
|
| 1-Methyl-3-isobutylxanthine | 1 | 1997 | 13 | 0.010 |
Why?
|
| Molecular Structure | 1 | 1998 | 515 | 0.010 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1997 | 226 | 0.010 |
Why?
|
| Genistein | 1 | 1997 | 73 | 0.010 |
Why?
|
| Staurosporine | 1 | 1997 | 143 | 0.010 |
Why?
|
| Isoflavones | 1 | 1997 | 72 | 0.010 |
Why?
|
| Isoquinolines | 1 | 1997 | 116 | 0.010 |
Why?
|
| Naphthalenes | 1 | 1997 | 83 | 0.010 |
Why?
|
| Cell Cycle | 1 | 1982 | 2084 | 0.010 |
Why?
|
| Chromatography, Paper | 2 | 1972 | 6 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 1998 | 571 | 0.010 |
Why?
|
| Centromere | 1 | 1996 | 97 | 0.010 |
Why?
|
| Computer Communication Networks | 1 | 1996 | 44 | 0.010 |
Why?
|
| Uracil Nucleotides | 1 | 1974 | 12 | 0.010 |
Why?
|
| Hydrochloric Acid | 1 | 1974 | 19 | 0.010 |
Why?
|
| Sodium Hydroxide | 1 | 1974 | 16 | 0.010 |
Why?
|
| Pancreas | 2 | 1973 | 718 | 0.010 |
Why?
|
| G1 Phase | 1 | 1996 | 285 | 0.010 |
Why?
|
| Carbon Isotopes | 2 | 1972 | 333 | 0.010 |
Why?
|
| Histones | 1 | 1982 | 1466 | 0.010 |
Why?
|
| Rodentia | 1 | 1974 | 65 | 0.010 |
Why?
|
| DNA-Directed RNA Polymerases | 1 | 1974 | 97 | 0.010 |
Why?
|
| Blood Cells | 1 | 1974 | 127 | 0.010 |
Why?
|
| Prognosis | 1 | 2011 | 21713 | 0.010 |
Why?
|
| Phosphorus Isotopes | 1 | 1972 | 5 | 0.010 |
Why?
|
| Snakes | 1 | 1972 | 7 | 0.010 |
Why?
|
| Chemistry | 1 | 1972 | 99 | 0.010 |
Why?
|
| Chemical Phenomena | 1 | 1972 | 137 | 0.010 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2004 | 2527 | 0.010 |
Why?
|
| Tetraethylammonium | 1 | 1992 | 14 | 0.010 |
Why?
|
| Cimetidine | 1 | 1992 | 28 | 0.010 |
Why?
|
| Culture Techniques | 1 | 1992 | 132 | 0.010 |
Why?
|
| Syndrome | 1 | 1996 | 1351 | 0.010 |
Why?
|
| Hydrolysis | 1 | 1972 | 227 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2012 | 29902 | 0.010 |
Why?
|
| Cell Membrane | 1 | 1975 | 850 | 0.010 |
Why?
|
| Genes, Tumor Suppressor | 1 | 1996 | 1064 | 0.010 |
Why?
|
| Nucleic Acid Conformation | 1 | 1972 | 279 | 0.010 |
Why?
|
| Leukemia, Myeloid | 1 | 1976 | 941 | 0.010 |
Why?
|
| Leukemia L1210 | 1 | 1991 | 54 | 0.010 |
Why?
|
| Cattle | 1 | 1972 | 783 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 1991 | 406 | 0.010 |
Why?
|
| Skin | 1 | 1974 | 1259 | 0.010 |
Why?
|
| Databases, Factual | 1 | 1996 | 2218 | 0.010 |
Why?
|
| Escherichia coli | 1 | 1974 | 1203 | 0.000 |
Why?
|
| Leukemia, Lymphoid | 1 | 1978 | 276 | 0.000 |
Why?
|
| DNA, Viral | 2 | 1973 | 694 | 0.000 |
Why?
|
| Capsid | 1 | 1987 | 103 | 0.000 |
Why?
|
| Antigens, Viral | 1 | 1987 | 471 | 0.000 |
Why?
|
| Trichloroacetic Acid | 1 | 1973 | 6 | 0.000 |
Why?
|
| Phosphorus Radioisotopes | 1 | 1973 | 44 | 0.000 |
Why?
|
| Coliphages | 1 | 1973 | 10 | 0.000 |
Why?
|
| Nucleic Acid Denaturation | 1 | 1973 | 34 | 0.000 |
Why?
|
| Thymidine | 1 | 1973 | 155 | 0.000 |
Why?
|
| Solubility | 1 | 1973 | 242 | 0.000 |
Why?
|
| Cytoplasm | 1 | 1977 | 652 | 0.000 |
Why?
|
| In Vitro Techniques | 1 | 1977 | 1618 | 0.000 |
Why?
|
| RNA, Bacterial | 1 | 1972 | 80 | 0.000 |
Why?
|
| Sucrose | 1 | 1972 | 64 | 0.000 |
Why?
|
| Lung | 1 | 1973 | 3151 | 0.000 |
Why?
|
| Bacteriophages | 1 | 1972 | 71 | 0.000 |
Why?
|
| Drug Interactions | 1 | 1972 | 553 | 0.000 |
Why?
|